ralpancizumab (RN317) / Pfizer  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ralpancizumab (RN317) / Pfizer
NCT01720537: A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Completed
1
133
US
PF-05335810 Dose A, PF-05335810 Dose B, Placebo, PF-04950615 Dose A, PF-05335810 Dose C, PF-04950615, PF-05335810 Dose D, PF-05335810 Dose E
Pfizer
Hypercholesterolemia
10/13
10/13

Download Options